Research Keyword: drug safety

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

Isavuconazole is an antifungal medication used to treat serious fungal infections in people with weakened immune systems. This study reviewed and analyzed three clinical trials to compare how well isavuconazole works compared to other antifungal drugs. The results showed that isavuconazole is just as effective as other antifungals but has fewer side effects, particularly fewer problems with liver health and drug-related adverse events. This makes isavuconazole a good alternative choice for patients who cannot use other antifungal medications or who are at risk of liver damage.

Read More »

Promoting rational herb-drug use through pharmacy-led advice and home visits in NCD patients

mycolabadmin

This study showed that when pharmacists visited NCD patients at home and provided education about the risks of combining herbal products with prescribed medications, patients significantly improved their knowledge and safe usage behaviors. The intervention successfully reduced the number of patients at risk of harmful herb-drug interactions from 37.5% to 25%. The findings suggest that simple home-based pharmacist counseling can be an effective way to help chronic disease patients safely use both herbs and medications together.

Read More »

Identification of (Z)-2-benzylidene-dihydroimidazothiazolone derivatives as tyrosinase inhibitors: Anti-melanogenic effects and in silico studies

mycolabadmin

Scientists developed new chemical compounds that can block tyrosinase, an enzyme that produces skin pigment (melanin). These new compounds, called DHIT derivatives, work much better than existing skin lightening agents like kojic acid and appear to be safer. The best compound tested was 100 times more effective at stopping melanin production than kojic acid in laboratory tests and showed no toxicity to cells.

Read More »
Scroll to Top